Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LINCO Diagnostic Services was a specialized contract research organization (CRO) providing bioanalytical services to the pharmaceutical and biotechnology sectors. The company was renowned for its expertise in metabolic and endocrine biomarkers, offering CLIA-certified testing for clinical trials. Their service portfolio included assay development, validation, and sample analysis using technologies such as ELISA, RIA, and Luminex multiplexing. In 2006, the company was acquired by Millipore Corporation, integrating its capabilities into Millipore's Bioscience division. Today, its legacy continues within the MilliporeSigma brand of Merck KGaA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LINCO Diagnostic Services.